{"name":"Adnexus, A Bristol-Myers Squibb R&D Company","slug":"adnexus-a-bristol-myers-squibb-r-d-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQRjNaT21MM0UxX2lwREpKVW5ybWYyYmhlazE4WU1YS1VTNVJ0QzdPTWlMTl8zRXNkSUFYbWtGcUdDeVBuNVhZbldONFcxYzk4SjlxcXlORFRZSXU3cE1LbVlkblJobTc4eXg3UFBmQmFPLXZnV0VkQnpnWm5PancxX0JaZ0lZNXVibnFZMTVPdXAyTDAtM1luOElZQmNLdWhYOWNtenJHSlRYak5iZFREQ1JUbnM3M0V6U2c?oc=5","date":"2018-01-04","type":"pipeline","source":"Pharmafile","summary":"Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy - Pharmafile","headline":"Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOYkR3MWU5eWtSSXFOZjBzVFI1VWJ4ekxoekJ2cjh2S1FJODdvcUtZa3RZVDc2LVl5b3gwZUx3TVZwa0N6Z0VEdUpsWUlDUjR2R2xQeWljVERZVEZLMzNpS1FyRmtQcmNxVER2bzVwdkFIT0dYdUlSQzU3MGtyX1NYUXFEOVptcldQRU80QVJMdk5ySi1GeDlHbU1KUnhET2lEM0JMME1LdEx4TG03anhXNVVSdE01V2VLWW0xUldrOXBtaEFKWGJqdg?oc=5","date":"2017-04-13","type":"pipeline","source":"Fierce Biotech","summary":"Bristol-Myers offloads anti-tau, DMD assets to Biogen, Roche for $470M upfront, $615M in milestones - Fierce Biotech","headline":"Bristol-Myers offloads anti-tau, DMD assets to Biogen, Roche for $470M upfront, $615M in milestones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPZXkxelNPalB0WDhyVUQtcEkwei1BdHExV1ZYdXB3V1hlNS1ValhKWEpabC1MZE1tZ1hHbm8tLVE4QVdGMWFiazFMc1k4U05jaTdCMmlXcjQteE9sWkx0NlBJZnVrU0g4MUF0bU9mZGdSTEdsWDdnWndpNGNEZVc3T3BPMFFLUlRVS1pUMjJ5d1VUaXVkb1JNR2VfY3lYNnZiYXRDNkhPbldtRDZ5?oc=5","date":"2015-06-25","type":"pipeline","source":"The Business Journals","summary":"Bristol-Myers Squibb to open Cambridge R&D center - The Business Journals","headline":"Bristol-Myers Squibb to open Cambridge R&D center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPRDVuOTV5QkNfRThhODFIbEl4ZUZKV04zdGJ0b0t6WThBM1BLcE54ZlJFZ1BJU25USE5aS0hLQm1ENW54ZjdXR2NmWGVSNDZQVG1nQ1poQ0ZnSFlodWtFbUhJM2JDV2JvbXZmX3RUZkNWRGxaeEdISERaMHpLU2d6bWFiNnhlOXdnSDRiX2ZmenVIQXdMNGgtZExFMWFfaU5BbWpIQmgzalozVWVuYWEyYnVQem45VGh1bmtEVXZBcw?oc=5","date":"2013-05-28","type":"pipeline","source":"Community News","summary":"Newsmakers - Community News","headline":"Newsmakers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}